INNOCAN PHARMA CORPORATION

Insiders InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Market Closed - Canadian Securities Exchange Other stock markets 20:48:20 08/05/2024 BST			5-day change	1st Jan Change
0.285 ^CAD	+1.79%		+5.56%	-8.06%

04-22	InnoCan Pharma Corporation Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain	CI
04-01	InnoCan Pharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InnoCan Pharma Corporation Announces Appointment of Dr. Joseph V. Pergolizzi to its Scientific Advisory Board	15/09/23	CI
Innocan Pharma Corporation Announces the Addition of Givi Topchishvili, to Advisory Committee, as A Business Strategy Adviser	18/11/22	CI
InnoCan Pharma Corporation Appoints Roni Kamhi as Chief Operating Officer	11/08/22	CI
Innocan Pharma Corporation Announces Appointment of Dr. Kenji Kitatani to Advisory Committee	07/02/22	CI
Iinnocan Pharma Corporation Announces Addition of Izhar Shay to its Advisory Committee	14/07/21	CI
Innocan Pharma Corporation Appoints Richard Serbin to its Advisory Committee	06/04/21	CI
InnoCan Pharma Corporation Appoints Mitchell Kline to Its Scientific Advisory Committee	23/03/21	CI
Innocan Pharma Corporation Announces Resignation of Bill Macdonald as Member of Board of Directors	02/07/20	CI
InnoCan Pharma Corporation Adds Peter Bloch to Its Board of Directors	23/01/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer